These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15166923)

  • 1. Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant.
    Thom J; Ivey L; Gilmore G; Eikelboom JW
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):353-7. PubMed ID: 15166923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
    Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H
    Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of lupus anticoagulant by means of dilute Russell's viper venom time is affected by oral anticoagulant therapy.
    Jouhikainen T
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):627-32. PubMed ID: 2133242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin does not interfere with lupus anticoagulant detection by dilute Russell's viper venom time.
    Olteanu H; Downes KA; Patel J; Praprotnik D; Sarode R
    Clin Lab; 2009; 55(3-4):138-42. PubMed ID: 19462936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dilute Russell's viper venom time.
    Radhakrishnan K
    Methods Mol Biol; 2013; 992():341-8. PubMed ID: 23546726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection with improved specificity.
    Moore GW; Peyrafitte M; Dunois C; Amiral J
    Lupus; 2018 Jan; 27(1):95-104. PubMed ID: 28549386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring warfarin therapy in patients with lupus anticoagulants.
    Moll S; Ortel TL
    Ann Intern Med; 1997 Aug; 127(3):177-85. PubMed ID: 9245222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring therapy with vitamin K antagonists in patients with lupus anticoagulant: effect on different tests for INR determination.
    Bijsterveld NR; Middeldorp S; Berends F; Büller HR
    J Thromb Thrombolysis; 2000 Apr; 9(3):263-9. PubMed ID: 10728026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of Russell's viper venom affects the sensitivity of the dilute Russell's viper venom time to lupus anticoagulants.
    Moore GW; Savidge GF
    Blood Coagul Fibrinolysis; 2004 Apr; 15(3):279-82. PubMed ID: 15060428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin monitoring in antiphospholipid syndrome and lupus anticoagulant.
    Crowl A; Schullo-Feulner A; Moon JY
    Ann Pharmacother; 2014 Nov; 48(11):1479-83. PubMed ID: 25104566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
    Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Taipan snake venom time: a new test for lupus anticoagulant.
    Rooney AM; McNally T; Mackie IJ; Machin SJ
    J Clin Pathol; 1994 Jun; 47(6):497-501. PubMed ID: 8063928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dilute Russell's viper venom and activated partial thromboplastin time in lupus anticoagulant diagnosis: is mixing essential?
    Chandrashekar V
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):408-11. PubMed ID: 26626041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying index of circulating anticoagulant to mixing tests with lupus anticoagulant screen and confirm reagents can distinguish with high specificity between lupus anticoagulants and direct factor Xa inhibitors.
    Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
    Int J Lab Hematol; 2021 Aug; 43(4):771-778. PubMed ID: 33974363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant.
    Rosborough TK; Shepherd MF
    Pharmacotherapy; 2004 Jul; 24(7):838-42. PubMed ID: 15303447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new-generation dilute Russell's viper venom time assay system for lupus anticoagulants: evaluation of detection utilising frozen reagents and controls.
    Moore GW; Tugnait S; Savidge GF
    Br J Biomed Sci; 2005; 62(3):127-32. PubMed ID: 16196459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of the Taipan snake venom assay in assessing lupus anticoagulant status in individuals receiving or not receiving an oral vitamin K antagonist.
    Parmar K; Lefkou E; Doughty H; Connor P; Hunt BJ
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):271-5. PubMed ID: 19530340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of four coagulation tests to detect plasma lupus anticoagulants.
    Saxena R; Saraya AK; Kotte VK; Singh YN; Prasad L; Malviya AN
    Am J Clin Pathol; 1991 Dec; 96(6):755-8. PubMed ID: 1746492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting.
    Antovic A; Norberg EM; Berndtsson M; Rasmuson A; Malmström RE; Skeppholm M; Antovic J
    Thromb Haemost; 2017 Aug; 117(9):1700-1704. PubMed ID: 28640321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.